Skip to main content
Premium Trial:

Request an Annual Quote

FDA Names Commissioner to Replace Crawford; Prolexys, Pathways Diagnostics, Assay Designs Taps New CEOs; UCSC s Haussler Awarded Dickson Prize; GenoLogics and Genizon Build Management Teams; and Others

Andrew von Eschenbach  has been named acting commissioner of the US Food and Drug Administration , following the resignation of former commissioner Lester Crawford last week.


Von Eschenbach has been director of the National Cancer Institute , part of the National Institutes of Health , since January 2002. Before that, he worked as a doctor and executive at the M D Anderson Cancer Center  in Houston. Von Eschenbach has said that he intends to act as both head of the FDA and director of NCI.


The appointment ends the tenure of Crawford who resigned last Friday.


Crawford, a veterinarian and expert on food safety, was named deputy commissioner of the agency in early 2002 before his tenure as acting commissioner began last year.


In a message to colleagues, Crawford cited his age - 67 - as a factor in his decision to step aside.


Douglas Throckmorton  has been named deputy director of the Center for Drug Evaluation and Research by the FDA. Throckmorton joined the FDA in 1997 and has been acting deputy director of CDER since May 2004.


Before joining the FDA, Throckmorton practiced medicine and held academic appointments at the Medical College of Georgia  and the VA Medical Center in Augusta, GA.

Prolexys Pharmaceuticals  has named David Clark as president and chief executive officer, the biopharmaceutical company said this week.


Clark comes to Prolexys from NPS Pharmaceuticals  where he served as vice president of corporate affairs at NPS Pharmaceuticals. Before he joined NPS, Clark was VP of business development for Agridyne Technologies .


Clark holds an MSc in agronomy from the University of Illinois and an MBA from the  University of Utah .

Walter Narajowski  has been named president and CEO of Pathways Diagnostics , the assay development company said this week. He will also join the firm's board of directors.


Narajowski was formerly the vice president and general manager of Focus Diagnostics ' infectious disease reference lab. Prior to Focus, Mr. Narajowski spent over 20 years at Abbott Laboratories  where he was most recently vice president and general manager of critical care products and vice president and general manager of the infusion pump business.


Narajowski holds an MS in bioengineering from the  University of Utah and a BSc in electrical engineering from Illinois Institute of Technology .

Assay Designs  has appointed Gustavo Salem as its new president and CEO, the Ann Arbor, Mich.-based biotech firm said last week.


Prior to joining Assay Designs, Salem held a variety of positions at Bio-Rad Laboratories , including division manager of protein separations and business unit manager for biomaterials. Prior to this, he held a series of sales and marketing positions at PerSeptive Biosystems , Beckman Instruments , and  Amersham .

Cheri Walker  has been named vice president of mergers and acquisitions of Qiagen . Walker joined the firm last week from Invitrogen , where she most recently held the position of vice president of proteomics. She had joined Invitrogen in December 2003 as vice president, corporate development. Prior to working at Invitrogen, Walker was an equity analyst with Deutsche Bank covering the life sciences tools industry.


Invitrogen promoted Chuck Piazza  to the position of vice president and general manager of proteomics, following Walker's departure. Piazza had held the position of vice president and general manager of protein arrays before the promotion. Invitrogen also named Don Daut vice president and general manager of its Antibody Center of Excellence.

Carnegie Mellon University will award its prestigious Dickson Prize in Science to David Haussler , a professor of biomolecular engineering at the University of California, Santa Cruz .


Haussler will receive an award of $50,000 and will deliver a public lecture as part of the prize ceremony to be held at Carnegie Mellon University in March 2006.


Haussler is the director of the Center for Biomolecular Science and Engineering  at UCSC and is scientific co-director of the California Institute for Quantitative Biomedical Research (QB3).


Since 1970, Carnegie Mellon has awarded the Dickson Prize to prominent researchers in such areas as mathematics, cell biology, civil engineering, metallurgy, computer science, genetics, and physics.

GenoLogics Life Sciences Software  expanded its management team this week with several new appointments.


The Canadian bioinformatics company named Greg Kinch  as vice president of sales, and joined GenoLogics from Silicon Genetics , now Agilent Technologies . He previously held sales leadership positions at Genomic Solutions , BI Systems , and other companies in the life sciences industry.


Rob Milne , who previously held engineering and R&D executive positions with Nokia , Vienna Systems , Motorola  and Mitel, has been appointed VP of product development.


Gail McBride , the firm's new VP of marketing comes to GenoLogics from ALI Technologies , while David Slater-Kinghorn , who has been named VP of finance, formerly held positions at LifeScan Canada , a Johnson & Johnson Company, CanWel Distribution  and Sappi Export Services .


Brandie Yarish  has been named manager of human resources, and, to round out the new appointments, James DeGreef , a co-founder of GenoLogics, will assume the position of VP of product management.

Genizon BioSciences  added to its management team this week by naming Claude Lambert to the position of vice president and chief financial officer and Renno Schuurmans as VP of business development, Europe.


Lambert previously served as vice president, finance and administration of ProMetic Life Sciences , a public Canadian biotechnology company, and Adaltis .


Schuurmans has held senior sales and marketing positions at InnaPhase Corp, Araccel BV  and Phoenix International Life Sciences . He holds a PhD from the University of Amsterdam and completed his post-doctoral research at the Max Plank Institute and  Northwestern University .

Sciona  has appointed David Castle to chair its new ethics advisory board, the Boulder, Colo.-based company said this week.


Castle is currently an associate professor at University of  Guelph, a member of the Joint Centre for Bioethics at the  University of Toronto and a member of McGill University's Centre for Intellectual Property Policy . He is also a principal investigator on three large-scale Genome Canada funded Genomics, Ethics, Law and Society research programs.


He holds a BSc in biology from  University of Alberta , an MA in philosophy from McMaster University  and a PhD in philosophy from the  University of Guelph .

Peter Schultz  has joined the board of directors at Nanosphere , the life sciences company said this week.


Schultz is currently on the faculty at The Scripps Research Institute  in La Jolla, Calif., where he holds the Scripps Family Chair as a professor of chemistry, and is director of the Genomics Institute of the Novartis Research Foundation , also in La Jolla.


Schultz also helped found the Affymax Research Institute , Symyx Technologies , Ambrx , Syrrx , Kalypsys , Phenomix , and Ilypsa .


He holds a BA and a PhD from the California Institute of Technology .

ForteBio  recently named Stephen Oldfield to the new position of vice president of marketing and sales.


Oldfield joined ForteBio in early August from Molecular Devices , where he was vice president of worldwide marketing. He will be responsible for recruiting marketing and sales personnel in support of ForteBio's first product launch later this year, ForteBio said. Prior to his employment with Molecular Devices, Oldfield held senior marketing positions at Molecular Probes, FMC BioProducts , Molecular Dynamics , and Pharmacia Biotechnology  AB. Oldfield received a PhD in pure and applied biology from the  Imperial College, London , and a BS in genetics from the University of Sheffield in the UK.

Bionovo  has appointed Zung Vu Tran to its scientific advisory board. Tran is a research professor in the department of preventive medicine and biostatistics at the  University of Colorado at Denver and Health Sciences Center in Denver and is a member of the University of Colorado Cancer Center 's biostatistics and bioinformatics core.

Neil Kipling , founder, CEO, and chairman of IDBS , has been awarded the 2005 SBS Accomplishment Award for Innovation in Information Management for Scientific Software . The Society for Biomolecular Screening  presented the award earlier this month at its 11th Annual SBS Conference and Exhibition in Geneva. The award carries a $1,000 honorarium, which Kipling is donating to the Sunflower Trust , a charitable organization dedicated to helping children with learning difficulties based in Guildford, UK, where IDBS is headquartered.

Daniel Von Hoff  has been named to Innovive Pharmaceuticals ' scientific advisory board, the New York-based company said this week.


Von Hoff is currently the senior investigator and head of translational research at the Translational Genomics Research Institute  in its translational drug development division. He also is chief scientific officer for US Oncology .

Nanoscience Technologies  has appointed David Keenan to the position of resident and chief executive officer.


He previously served as business development manager at Advanced MicroMachines , a business within Goodrich' s sensor systems division. He has also worked at Sheldahl  and 3M .


Keenan holds a BS in Chemical Engineering from the University of Wisconsin and an MS in management technology from the University of Minnesota .

Genomic Profiling Systems  this week named David Jones to the position of director of technical services, the Bedford, Mass.-based firm said.


Jones joins GPS from Wyeth Biopharma  where he served as manager of Microbial Test Technologies since 2003. He has also held positions at Chemunex from 1997 to 2002 and Anagen .


He holds an MS from  Brunel University in applied biochemistry and a PhD in steroid endocrinology from St. Mary's Hospital Medical School in London .


GPS also named Tracey Wielinski  as vice president of quality assurance and regulatory affairs this week. She formerly was VP of corporate quality and compliance at Oscient Pharmaceuticals .


Wielinski holds a BA in biology and communications from University of Toledo .

Promoted? Changing jobs? GenomeWeb News wants to know. E-mail us at   [email protected] to announce your move in PEOPLE, a weekly roundup of personnel changes in the genomics industry.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.